Review: taking Singulair and Neurontin together


Summary

Drug interactions are reported among people who take Singulair and Neurontin together. This review analyzes the effectiveness and drug interactions between Singulair and Neurontin. It is created by eHealthMe based on reports of 2,153 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Singulair and Neurontin >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Singulair

Singulair has active ingredients of montelukast sodium. It is often used in asthma. (latest outcomes from Singulair 42,094 users)

Neurontin

Neurontin has active ingredients of gabapentin. It is often used in pain. (latest outcomes from Neurontin 56,860 users)

On Jul, 30, 2016

2,153 people who take Singulair, Neurontin are studied.


Number of reports submitted per year:

Singulair and Neurontin drug interactions.

Drug effectiveness over time:

Singulair:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 7.0% - (1 of 14 people)
  • 6 - 12 months: 37.0% - (3 of 8 people)
  • 1 - 2 years: 69.0% - (9 of 13 people)
  • 2 - 5 years: 47.0% - (9 of 19 people)
  • 5 - 10 years: 87.0% - (14 of 16 people)
  • 10+ years: 63.0% - (7 of 11 people)
  • not specified: 100.0% - (2 of 2 people)
Neurontin:
  • < 1 month: 25.0% - (1 of 4 people)
  • 1 - 6 months: 7.0% - (1 of 13 people)
  • 6 - 12 months: 44.0% - (4 of 9 people)
  • 1 - 2 years: 42.0% - (9 of 21 people)
  • 2 - 5 years: 61.0% - (8 of 13 people)
  • 5 - 10 years: 57.0% - (12 of 21 people)
  • 10+ years: 0.0% - (0 of 2 people)
  • not specified: 33.0% - (1 of 3 people)

Drug effectiveness by gender:

Singulair:
  • female: 60.0% - (39 of 64 people)
  • male: 31.0% - (6 of 19 people)
Neurontin:
  • female: 47.0% - (32 of 68 people)
  • male: 22.0% - (4 of 18 people)

Drug effectiveness by age:

Singulair:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 1 people)
  • 10-19: 0.0% - (0 of 1 people)
  • 20-29: 100.0% - (6 of 6 people)
  • 30-39: 78.0% - (11 of 14 people)
  • 40-49: 44.0% - (12 of 27 people)
  • 50-59: 50.0% - (8 of 16 people)
  • 60+: 44.0% - (8 of 18 people)
Neurontin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 100.0% - (1 of 1 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 40.0% - (2 of 5 people)
  • 30-39: 14.0% - (2 of 14 people)
  • 40-49: 56.0% - (18 of 32 people)
  • 50-59: 37.0% - (6 of 16 people)
  • 60+: 38.0% - (7 of 18 people)

Most common drug interactions over time *:

< 1 month:
  • dizziness
  • nausea
  • balance disorder
  • drug ineffective
  • orthostatic hypotension
  • fall
  • gastric disorder
  • malaise
  • somnolence
  • thinking abnormal
1 - 6 months:
  • asthma
  • multiple allergies
  • runny nose
  • excessive thirst
  • nausea
  • urinary retention
  • abdominal pain aggravated
  • abdominal pain upper
  • cough
  • dizziness
6 - 12 months:
  • hiccups
  • cough
  • depression
  • fatigue
  • pain - shoulder
  • shortness of breath
  • abdominal abscess
  • abscess - skin
  • aggression
  • anger
1 - 2 years:
  • acid reflux
  • crepitus
  • itching
  • neck pain
  • allergy to animal
  • allergy to chemicals
  • allergy to plants
  • anxiety
  • back pain - low
  • eczema
2 - 5 years:
  • anxiety
  • convulsion
  • migraine
  • pain in extremity
  • anaemia
  • asthenia
  • depression
  • dizziness
  • fatigue
  • haematochezia
5 - 10 years:
  • asthma
  • anxiety
  • crepitus
  • multiple allergies
  • runny nose
  • acid reflux
  • allergy to animal
  • allergy to chemicals
  • allergy to plants
  • back pain - low
10+ years:
  • edema - peripheral, peripheral edema
  • asthma
  • atrial fibrillation
  • cough
  • nosebleed
  • shortness of breath
  • abdominal pain upper
  • anxiety aggravated
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • frequent headaches
not specified:
  • pain
  • nausea
  • anxiety
  • dyspnoea
  • chest pain
  • dizziness
  • fall
  • arthralgia
  • pain in extremity
  • back pain

Most common drug interactions by gender *:

female:
  • pain
  • nausea
  • dyspnoea
  • fall
  • anxiety
  • arthralgia
  • dizziness
  • drug ineffective
  • vomiting
  • chest pain
male:
  • anxiety
  • pain
  • pneumonia
  • anaemia
  • headache
  • neuropathy peripheral
  • chronic obstructive pulmonary disease
  • chest pain
  • back pain
  • dizziness

Most common drug interactions by age *:

0-1:
  • orthostatic hypotension
  • pulmonary hypertension
  • bronchospasm
  • chest pain
  • convulsion
  • nephrolithiasis
  • pericardial effusion
  • sepsis
  • type 2 diabetes mellitus
  • urinary tract infection
2-9:
  • adenovirus test positive
  • application site irritation
  • application site pain
  • application site urticaria
  • cardiac arrest
  • chronic graft versus host disease
  • convulsion
  • hypertension
  • multi-organ disorder
  • nausea
10-19:
  • convulsion
  • migraine
  • benign intracranial hypertension
  • abdominal pain upper
  • depression
  • diplopia
  • dysgeusia
  • dyspnoea
  • electrocardiogram qt prolonged
  • fatigue
20-29:
  • dyspnoea
  • neuropathy peripheral
  • hodgkin's disease
  • impetigo
  • keratoconjunctivitis sicca
  • lacrimation increased
  • lung disorder
  • lymphadenopathy
  • oral herpes
  • palpitations
30-39:
  • anxiety
  • type 2 diabetes mellitus
  • abdominal pain
  • dyspnoea
  • pain
  • hypersensitivity
  • nausea
  • diabetes mellitus
  • oedema peripheral
  • pulmonary embolism
40-49:
  • pain
  • pancreatitis
  • drug ineffective
  • asthma
  • chest pain
  • nausea
  • nephrogenic systemic fibrosis
  • anxiety
  • headache
  • asthenia
50-59:
  • pain
  • anxiety
  • fall
  • pyrexia
  • nausea
  • dizziness
  • arthralgia
  • pain in extremity
  • chest pain
  • injury
60+:
  • pain
  • dyspnoea
  • back pain
  • pneumonia
  • asthenia
  • chronic obstructive pulmonary disease
  • dizziness
  • nausea
  • arthralgia
  • oedema peripheral

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Singulair and Neurontin?

Can you answer these questions?

More questions for: Singulair, Neurontin

You may be interested in these reviews

More reviews for: Singulair, Neurontin

On eHealthMe, Singulair (montelukast sodium) is often used to treat asthma. Neurontin (gabapentin) is often used to treat pain. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.